SCHEMBL4131098

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4139907	0.92	TLR7 (0.57)	TLR7
	SCHEMBL1146558	0.92	TLR7 (0.59)	TLR7
	SCHEMBL13871701	0.91	TLR7 (0.56)	TLR7
	SCHEMBL4134546	0.90	TLR7 (0.60)	TLR7
	SCHEMBL12726719	0.89	TLR7 (0.59)	TLR7
	SCHEMBL20741418	0.89	TLR7 (0.59)	TLR7
	SCHEMBL26354070	0.89	TLR7 (0.61)	TLR7
	SCHEMBL7210381	0.89	TLR7 (0.73)	TLR7
	SCHEMBL24247653	0.89	TLR7 (0.53)	TLR7IL6
	SCHEMBL22510319	0.89	TLR7 (0.53)	TLR7IL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.